Background: Grading upper tract urothelial carcinomas (UTUC) in cell blocks with small distorted tissue fragments can be challenging; interobserver agreement is poor among pathologists. Mitotic figure (MF) counting along with nuclear features is important in grading these tumors. We evaluated the use of the mitotic-specific marker phosphohistone H3 (PHH3) as an adjunct to hematoxylin and eosin (H&E) stain for grading UTUC in cell blocks. Methods: Formalin-fixed, paraffin-embedded tissues from the cell blocks of 61 UTUC were stained with H&E and PHH3 antibody. The grading of tumors was performed independently by 3 pathologists, on both H&E-stained and PHH3 plus H&E-stained slides. The grading system used was the 1973 WHO 3-point grading system. Gradings were compared by all the pathologists for H&E staining versus PHH3 plus H&E staining with the Stuart-Maxwell test of marginal homogeneity that accounts for the matched data. Results: The average pairwise agreement by H&E alone was 55%, and 80% by PHH3 plus H&E. Conclusion: By adding PHH3 immunostain to the H&E, the agreement in grading the carcinomas among the 3 pathologists improved dramatically. PHH3 immunostain may play an important role in grading UTUC in small cell block samples.

Chen GL, Bagley DH: Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys. J Urol 2000;164:1173.
Elliott DS, Segura JW, Lightner D, et al: Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney. Urology 2001;58:174.
Keeley FX, Bibbo M, Bagley DH: Ureteroscopic treatment and surveillance of upper tract transitional cell carcinoma. J Urol 1997;157:1560.
Tawfiek E, Bibbo M, Bagley DH: Ureteroscopic biopsy: technique and specimen preparation. Urology 1997;50:117.
Keeley FX, Kulp DA, Bibbo M, et al: Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma. J Urol 1997;157:33.
Mae TK, Teo I, Robertson SJ, Marginean EC, Islam S, Yasdi HM: Immunostaining as a diagnostic and in cytopathologic study of upper urinary tract urothelial carcinoma. Acta Cytol 2009;53:611–618.
Tapia C, Kutzner H, Mentzel T, Savic S, Baumhoer D, Glatz K: Two mitosis-specific antibodies, MPM-2 and phospho-histone H3 (Ser 28), allow rapid and precise determination of mitotic activity. Am J Surg Pathol 2006;30:83–89.
Nasr MR, El-Zammar O: Comparison of PHH3, Ki-67, and surviving immunoreactivity in benign and malignant lesions. Am J Dermatopathol 2008;30:117–122.
Veras E, Malpica A, Deavers MT, Silva EG: Mitosis-specific marker phospho-histone H3 in the assessment of mitotic index in uterine smooth muscle tumors: a pilot study. Int J Gynecol Pathol 2009;28:316–321.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.